Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care - Launay-Vacher, V; Rey, J B; Isnard-Bagnis, C (Cancer Chemother Pharmacol, 2008)
et al.